Resectability, Resections, Survival Outcomes, and Quality of Life in Older Adult Patients with Metastatic Colorectal Cancer (the RAXO-Study)

Older adults are underrepresented in metastatic colorectal cancer (mCRC) studies and thus may not receive optimal treatment, especially not metastasectomies. The prospective Finnish real-life RAXO-study included 1086 any organ mCRC patients. We assessed repeated centralized resectability, overall su...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JOURNAL OF CLINICAL MEDICINE 2023-05, Vol.12 (10), p.3541
Hauptverfasser: Lehtomäki, Kaisa, Soveri, Leena-Maija, Osterlund, Emerik, Lamminmäki, Annamarja, Uutela, Aki, Heervä, Eetu, Halonen, Päivi, Stedt, Hanna, Aho, Sonja, Muhonen, Timo, Ålgars, Annika, Salminen, Tapio, Kallio, Raija, Nordin, Arno, Aroviita, Laura, Nyandoto, Paul, Kononen, Juha, Glimelius, Bengt, Ristamäki, Raija, Isoniemi, Helena, Osterlund, Pia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Older adults are underrepresented in metastatic colorectal cancer (mCRC) studies and thus may not receive optimal treatment, especially not metastasectomies. The prospective Finnish real-life RAXO-study included 1086 any organ mCRC patients. We assessed repeated centralized resectability, overall survival (OS), and quality of life (QoL) using 15D and EORTC QLQ-C30/CR29. Older adults (>75 years; n = 181, 17%) had worse ECOG performance status than adults (
ISSN:2077-0383
2077-0383
DOI:10.3390/jcm12103541